Showing 85 to 96 of 121 results


2025 Economic Uncertainty: Interest Rates, Retirement Savings, and Financial Planning
In 2025, falling interest rates will lower savings returns but offer debt relief, while increased retirement contribution limits offset potential tax changes and market volatility, demanding proactive financial planning.
2025 Economic Uncertainty: Interest Rates, Retirement Savings, and Financial Planning
In 2025, falling interest rates will lower savings returns but offer debt relief, while increased retirement contribution limits offset potential tax changes and market volatility, demanding proactive financial planning.
Progress
36% Bias Score


AI Investment Surges in 2024: OpenAI Soars, xAI's Grok Takes a Different Path
In 2024, US AI investment hit $56 billion, driving OpenAI's valuation to $157 billion, while Elon Musk's xAI, despite its smaller size, is pursuing a user-adoption strategy with its chatbot Grok, which prioritizes speed over accuracy, leveraging data from X (formerly Twitter), and potentially integr...
AI Investment Surges in 2024: OpenAI Soars, xAI's Grok Takes a Different Path
In 2024, US AI investment hit $56 billion, driving OpenAI's valuation to $157 billion, while Elon Musk's xAI, despite its smaller size, is pursuing a user-adoption strategy with its chatbot Grok, which prioritizes speed over accuracy, leveraging data from X (formerly Twitter), and potentially integr...
Progress
48% Bias Score


CD Rates Dip Following Fed Rate Cuts: Strategies for Maximizing Returns
The average 12-month CD yield is 1.83%, down slightly from 1.86% a year ago, while top yields are around 4%; this reflects the Federal Reserve's recent interest rate adjustments. Experts recommend choosing CD terms based on individual financial goals and the need to access funds, suggesting strategi...
CD Rates Dip Following Fed Rate Cuts: Strategies for Maximizing Returns
The average 12-month CD yield is 1.83%, down slightly from 1.86% a year ago, while top yields are around 4%; this reflects the Federal Reserve's recent interest rate adjustments. Experts recommend choosing CD terms based on individual financial goals and the need to access funds, suggesting strategi...
Progress
48% Bias Score


Record Investment Fuels China's NEV Sector Growth
Avatr, Changan's NEV brand, raised $1.51 billion in Series C funding, the largest in China's auto industry this year, to fuel expansion, R&D, and its 2026 IPO, while U Power and Nio secured substantial investments to boost production and international presence.
Record Investment Fuels China's NEV Sector Growth
Avatr, Changan's NEV brand, raised $1.51 billion in Series C funding, the largest in China's auto industry this year, to fuel expansion, R&D, and its 2026 IPO, while U Power and Nio secured substantial investments to boost production and international presence.
Progress
60% Bias Score


Short-Term CD Rates Remain High Despite Fed Rate Cuts
The Federal Reserve's three 2024 rate cuts decreased the Fed rate by 1%, impacting high-yield savings and CDs; however, short-term CDs still offer competitive returns, with options like TotalBank's 3-month CD at 4.71% APY.
Short-Term CD Rates Remain High Despite Fed Rate Cuts
The Federal Reserve's three 2024 rate cuts decreased the Fed rate by 1%, impacting high-yield savings and CDs; however, short-term CDs still offer competitive returns, with options like TotalBank's 3-month CD at 4.71% APY.
Progress
44% Bias Score


Pension Funds Shift to Private Markets and Asian Emerging Markets
A new report reveals that global pension funds are shifting investments toward private markets and Asian emerging markets due to historically high levels in Western regulated markets and sustained buyback operations; private debt and Asian emerging market equities are seen as promising.
Pension Funds Shift to Private Markets and Asian Emerging Markets
A new report reveals that global pension funds are shifting investments toward private markets and Asian emerging markets due to historically high levels in Western regulated markets and sustained buyback operations; private debt and Asian emerging market equities are seen as promising.
Progress
20% Bias Score

Biotech Stocks Poised for 2025 Rebound
Biotech stocks are poised for a rebound in 2025, driven by increased merger and acquisition activity, new drug approvals, and a looming patent cliff forcing large pharmaceutical companies to seek innovative biotech partners; however, investors should focus on specific companies rather than broad ind...

Biotech Stocks Poised for 2025 Rebound
Biotech stocks are poised for a rebound in 2025, driven by increased merger and acquisition activity, new drug approvals, and a looming patent cliff forcing large pharmaceutical companies to seek innovative biotech partners; however, investors should focus on specific companies rather than broad ind...
Progress
48% Bias Score

HSBC Stock Rises 32% YTD on Strong Q3 Results and Strategic Initiatives
HSBC's stock has gained 32% year-to-date, outpacing the S&P 500, driven by strong Q3 2024 results showing \$17 billion in revenue (up 5% YoY) from wealth products and trading activities, despite lower net interest income. The bank's cost-cutting measures, restructuring, and capital return program al...

HSBC Stock Rises 32% YTD on Strong Q3 Results and Strategic Initiatives
HSBC's stock has gained 32% year-to-date, outpacing the S&P 500, driven by strong Q3 2024 results showing \$17 billion in revenue (up 5% YoY) from wealth products and trading activities, despite lower net interest income. The bank's cost-cutting measures, restructuring, and capital return program al...
Progress
40% Bias Score

Biotech's Binary Week: Mesoblast Soars, Percheron Crashes
In the final week of 2023, contrasting fortunes played out in the Australian biotech sector as Mesoblast shares soared 50% following US FDA approval, while Percheron shares crashed over 90% after a failed drug trial, highlighting the high-risk, high-reward nature of the industry.

Biotech's Binary Week: Mesoblast Soars, Percheron Crashes
In the final week of 2023, contrasting fortunes played out in the Australian biotech sector as Mesoblast shares soared 50% following US FDA approval, while Percheron shares crashed over 90% after a failed drug trial, highlighting the high-risk, high-reward nature of the industry.
Progress
60% Bias Score

AI-Fueled Power Sector Rally: Three Stocks Poised for Further Growth
The soaring demand for electricity from AI data centers has propelled Constellation Energy, Vistra Corp., and Talen Energy's stock prices to record highs in 2024, driven by their nuclear and gas assets crucial for powering AI infrastructure; however, securing further power purchase agreements remain...

AI-Fueled Power Sector Rally: Three Stocks Poised for Further Growth
The soaring demand for electricity from AI data centers has propelled Constellation Energy, Vistra Corp., and Talen Energy's stock prices to record highs in 2024, driven by their nuclear and gas assets crucial for powering AI infrastructure; however, securing further power purchase agreements remain...
Progress
48% Bias Score

Stellantis to Invest \$8 Billion in Italian Operations
Stellantis announced a \$2 billion investment in Italy next year and a further \$6 billion in its supply chain, increasing production at six Italian plants starting in 2026 with over a dozen new models by 2032, in response to concerns about job security after the merger of Fiat Chrysler and PSA Peug...

Stellantis to Invest \$8 Billion in Italian Operations
Stellantis announced a \$2 billion investment in Italy next year and a further \$6 billion in its supply chain, increasing production at six Italian plants starting in 2026 with over a dozen new models by 2032, in response to concerns about job security after the merger of Fiat Chrysler and PSA Peug...
Progress
36% Bias Score

Greece to Review Intervention in Swiss Franc Loans
Greek authorities are reviewing potential interventions in Swiss franc loans totaling €4.5 billion due to the strengthening Swiss franc against the euro, impacting borrowers' debt, while a new LNG-CNG station opens in Thriasio.

Greece to Review Intervention in Swiss Franc Loans
Greek authorities are reviewing potential interventions in Swiss franc loans totaling €4.5 billion due to the strengthening Swiss franc against the euro, impacting borrowers' debt, while a new LNG-CNG station opens in Thriasio.
Progress
24% Bias Score
Showing 85 to 96 of 121 results